Conditions: Pleuropulmonary Blastoma; Recurrent Malignant Peripheral Nerve Sheath Tumor; Recurrent Neuroblastoma; Recurrent Rhabdomyosarcoma; Recurrent Synovial Sarcoma; Wilms Tumor Interventions: Other: Laboratory Biomarker Analysis; Biological: Lorvotuzumab Mertansine; Other: Pharmacological Study
Principal Investigator:
Kirov, Ivan
Research Coordinator:
Tina Templeman
(714) 509-8646
Visit clinicaltrials.gov for more information about this trial.
- IRB Number: 151077
- Sponsor: COG
- Protocol Number: ADVL1522
- NCT Number: NCT02452554
- Research Type: Recurrent/Refractory Cancer, Solid Tumors
- Phase: II
- Status: Active - Closed to Enrollment
